Paula Chu
Impact in
-
- Iron Metabolism and Disorders
-
- Uterine Myomas and Treatments
Papers in
- Surgery 6
- Lipoproteins and Cardiovascular Health 3
- Pancreatitis Pathology and Treatment 2
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Sue J. Goldie (2 shared papers)M. G. Myriam Hunink (2 shared papers)Rinske A. Gotink (1 shared paper)Gloria Y. Yeh (1 shared paper)Sengwee Toh (1 shared paper)Alan M. Zaslavsky (1 shared paper)Stephen B. Soumerai (1 shared paper)Laura F. Garabedian (1 shared paper)
- Journals
- Atherosclerosis Supplements (2 papers)Value in Health (2 papers)Health Technology Assessment (1 paper)Annals of Internal Medicine (1 paper)Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Paula Chu
18 papers receiving 503 citations
Peers
Comparison fields: 5 of 92
- Hematology 60
- Obstetrics and Gynecology 40
- Genetics 45
- Cardiology and Cardiovascular Medicine 92
- Reproductive Medicine 32
Countries citing papers authored by Paula Chu
This map shows the geographic impact of Paula Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Chu more than expected).
Fields of papers citing papers by Paula Chu
This network shows the impact of papers produced by Paula Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Chu. The network helps show where Paula Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Paula Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 153 | |
| 2 | 2014 | 93 | |
| 3 | 2009 | 48 | |
| 4 | 2009 | 48 | |
| 5 | 2016 | 43 | |
| 6 | 2008 | 30 | |
| 7 | 2019 | 25 | |
| 8 | 2018 | 20 | |
| 9 | Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada. | 2009 | 13 |
| 10 | 2008 | 11 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2024 | 3 | |
| 15 | 2017 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2007 | 1 | |
| 18 | 2007 | 1 | |
| 19 | 2006 | 0 |
About Paula Chu
Paula Chu is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Economics and Econometrics, Oncology and Genetics, having authored 19 papers that have together received 525 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Lung Cancer Treatments and Mutations (4 papers), Lipoproteins and Cardiovascular Health (3 papers), Pharmaceutical Economics and Policy (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatitis Pathology and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Endometriosis Research and Treatment (2 papers). The work is most often cited by research in Hematology (60 citations), Obstetrics and Gynecology (40 citations), Genetics (45 citations), Cardiology and Cardiovascular Medicine (92 citations) and Reproductive Medicine (32 citations). Paula Chu has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Sue J. Goldie, M. G. Myriam Hunink, Rinske A. Gotink, Gloria Y. Yeh, Sengwee Toh, Alan M. Zaslavsky, Stephen B. Soumerai, Laura F. Garabedian, Ankur Pandya and David R. Thompson. Their work appears in journals such as Atherosclerosis Supplements, Value in Health, Health Technology Assessment, Annals of Internal Medicine and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.